<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Pharmacophore</journal-id>
      <journal-id journal-id-type="publisher-id">pharmacophorejournal.com</journal-id>
      <journal-id journal-id-type="publisher-id">Pharmacophore</journal-id>
      <journal-title-group>
        <journal-title>Pharmacophore</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2229-5402</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">pharmacophorejournal.com-6963</article-id>
      <article-id pub-id-type="doi">10.51847/4hFpoC4b6j</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Can Explanations Survive Biological Complexity? A Systematic Map of Explainable Artificial Intelligence in Omics-Driven Drug Discovery</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Mensah</surname>
                <given-names>Koffi</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Ouedraogo</surname>
                <given-names>Hawa</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Diallo</surname>
                <given-names>Ismael</given-names>
              </name>
                              <xref rid="aff3" ref-type="aff">3</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Becker</surname>
                <given-names>Stefan</given-names>
              </name>
                              <xref rid="aff4" ref-type="aff">4</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Traoré</surname>
                <given-names>Mahamadou</given-names>
              </name>
                              <xref rid="aff5" ref-type="aff">5</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Explainable AI in Omics-Driven Discovery, Faculty of Pharmacy, University of Ghana, Accra, Ghana.
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of Biological Complexity and Explanation Validity, Faculty of Pharmacy, University of Ouagadougou, Ouagadougou, Burkina Faso.
          </aff>
                  <aff id="aff3">
            <label>3</label>Department of Systematic Mapping of XAI in Drug Discovery, Faculty of Pharmaceutical Sciences, University of Niger, Niamey, Niger.
          </aff>
                  <aff id="aff4">
            <label>4</label>Department of Explanation Survival and Biological Context, Faculty of Veterinary Medicine, University of Zurich, Zurich, Switzerland.
          </aff>
                  <aff id="aff5">
            <label>5</label>Department of Omics-Driven Drug Discovery and Explainability, Faculty of Pharmacy, University of Abomey-Calavi, Cotonou, Benin.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="koffi.mensah@ug.edu.gh">koffi.mensah@ug.edu.gh</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>28</day>
        <month>06</month>
        <year>2026</year>
      </pub-date>
      <volume>16</volume>
      <issue>3</issue>
      <fpage>86</fpage>
      <lpage>95</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Pharmacophore
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Explainable artificial intelligence is increasingly used to interpret genomic, transcriptomic, and multi-omics models in drug discovery, yet the biological meaning of those explanations remains uncertain. High-dimensional dependence, pathway redundancy, incomplete prior knowledge, cohort and platform shifts, and context-specific regulation can make an explanation appear coherent while remaining unstable, model-contingent, or biologically circular. This systematic mapping review examines how explanation methods are defined, applied, and evaluated across omics-driven pharmaceutical research. A protocol-led mapping strategy was used to organize the selected peer-reviewed literature by omics layer, drug-discovery task, model architecture, explanation family, biological object, validation practice, expert involvement, and downstream decision relevance. The synthesis indicates that technical method availability is more mature than evidence of biological credibility. Feature attribution, perturbation analysis, rule extraction, attention-based interpretation, and biologically structured neural networks can reveal model-relevant patterns, but benchmark performance, pathway familiarity, and expert agreement do not alone establish mechanism, causality, or translational value. The review proposes an evidence hierarchy in which computational faithfulness, stability, context transportability, non-circular biological coherence, experimental confirmation, and decision utility are treated as distinct requirements. It also identifies major neglected areas, including cross-platform explanation replication, prospective experimental use, negative evidence, uncertainty communication, and controlled studies of expert decision impact. The central contribution is an evaluative map of where explanations are technically capable, scientifically plausible, weakly validated, or not yet ready to influence pharmaceutical decisions. The proposed standards are review-derived rather than empirically validated and require adaptation to specific biological systems, development stages, and decision consequences.</p>
      </abstract>
      <kwd-group>
                <kwd>Explainable artificial intelligence</kwd>
                <kwd>Omics data</kwd>
                <kwd>Drug discovery</kwd>
                <kwd>Biological interpretability</kwd>
                <kwd>Explanation faithfulness</kwd>
                <kwd>Context dependence</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>